Filing Details
- Accession Number:
- 0001104659-19-015691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-18 18:20:44
- Reporting Period:
- 2019-03-15
- Accepted Time:
- 2019-03-18 18:20:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1393434 | Ocular Therapeutix Inc | OCUL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691259 | H. Michael Goldstein | C/O Ocular Therapeutix, Inc. 15 Crosby Drive Bedford MA 01730 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-15 | 10,000 | $4.15 | 13,686 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 2,986 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018.
Billionaire Hedge Funds
